AstraZeneca Cash from Investing (TTM) Trends

AstraZeneca PLC (AZN)

68.53 +0.26 (+0.39%) USD | NASDAQ | Apr 17, 16:00

69.00 +0.47 (+0.69%) Pre-Market: 08:28

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2000. Upgrade now.

Date	Value
December 31, 2023	-4.064B
September 30, 2023	-3.236B
June 30, 2023	-3.758B
March 31, 2023	-4.038B
December 31, 2022	-2.96B
September 30, 2022	-3.624B
June 30, 2022	-12.34B
March 31, 2022	-11.78B
December 31, 2021	-11.06B
September 30, 2021	-10.01B
June 30, 2021	-123.00M
March 31, 2021	261.00M
December 31, 2020	-285.00M
September 30, 2020	-365.00M
June 30, 2020	289.00M
March 31, 2020	-976.00M
December 31, 2019	-657.00M
September 30, 2019	212.00M
June 30, 2019	-3.00M
March 31, 2019	1.018B
December 31, 2018	963.00M
September 30, 2018	-1.606B
June 30, 2018	-1.80B
March 31, 2018	-1.909B
December 31, 2017	-2.328B

Date	Value
September 30, 2017	-83.00M
June 30, 2017	-372.00M
March 31, 2017	-1.228B
December 31, 2016	-3.969B
September 30, 2016	-7.157B
June 30, 2016	-6.953B
March 31, 2016	-6.57B
December 31, 2015	-4.239B
September 30, 2015	-3.17B
June 30, 2015	-3.311B
March 31, 2015	-3.811B
December 31, 2014	-7.032B
September 30, 2014	-6.52B
June 30, 2014	-6.606B
March 31, 2014	-6.302B
December 31, 2013	-2.889B
September 30, 2013	-2.399B
June 30, 2013	-4.45B
March 31, 2013	-2.816B
December 31, 2012	-1.859B
September 30, 2012	-4.925B
June 30, 2012	-955.00M
March 31, 2012	-1.529B
December 31, 2011	-2.022B
September 30, 2011	1.106B

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-12.34B

Minimum

Jun 2022

289.00M

Maximum

Jun 2020

-3.606B

Average

-2.96B

Median

Dec 2022

Cash from Investing (TTM) Benchmarks